Biomarkers in heart failure - Better than history or echocardiography?

Herz

Volumn 34, Issue 8, 2009, Pages 581-588

  Berliner, Dominik ^a   Angermann, Christiane E ^a   Ertl, Georg ^a   Störk, Stefan ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Biomarker; Diagnostic utility; Heart failure; Natriuretic peptide

Indexed keywords

ADIPONECTIN; ADRENALIN; ADRENOMEDULLIN; ALDOSTERONE; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CARDIOTROPHIN 1; CATECHOLAMINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN; FATTY ACID BINDING PROTEIN; GALECTIN 3; GHRELIN; INTERLEUKIN 6; LEPTIN; MYELOPEROXIDASE; NATRIURETIC PEPTIDE TYPE C; NORADRENALIN; OSTEOPONTIN; RENIN; RESISTIN; SOMATOMEDIN C; TROPONIN; TUMOR NECROSIS FACTOR ALPHA; UROTENSIN II; VASOPRESSIN;

ALBUMIN BLOOD LEVEL; ANAMNESIS; BILIRUBIN BLOOD LEVEL; CELL DAMAGE; CELL STRESS; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE MARKER; DRUG DOSE INCREASE; DYSPNEA; ELECTROCARDIOGRAM; EVIDENCE BASED PRACTICE; EXTRACELLULAR MATRIX; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HUMAN; INFLAMMATION; MEDICAL DECISION MAKING; MUSCLE CELL; NATRIURESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SKILL; SODIUM BLOOD LEVEL; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; TACHYCARDIA; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; UREA NITROGEN BLOOD LEVEL;

BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; HEART FAILURE; HUMANS; MEDICAL HISTORY TAKING; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 73649098278     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3314-6     Document Type: Review

References (29)

1. C. Angermann C. Hoyer G. Ertl 2006 Differential diagnosis of dyspnea - significance of clinic aspects, imaging and biomarkers for the diagnosis of heart failure Clin Res Cardiol 95 Suppl4 57 70 10.1007/s00392-006-2009-8 1:CAS:528:DC%2BD28XkvFOnurs%3D 16598607
2. C.E. Angermann G. Ertl 2004 [Natriuretic peptides - new diagnostic markers in heart disease.] Herz 29 609 617 10.1007/s00059-004-2619-8 15912436 (Pubitemid 39366051)
3. E. Braunwald 2008 Biomarkers in heart failure N Engl J Med 358 2148 2159 10.1056/NEJMra0800239 1:CAS:528:DC%2BD1cXlvFCrsL8%3D 18480207 (Pubitemid 351679601)
4. K. Dickstein A. Cohen-Solal G. Filippatos, et al. 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 933 989 10.1016/j.ejheart. 2008.08.005 18826876
5. G.M. Felker V. Hasselblad A.F. Hernandez, et al. 2009 Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 422 430 10.1016/j.ahj.2009.06.018 1:CAS:528: DC%2BD1MXhtVegs7fP 19699866
6. G.C. Fonarow W.F. Peacock C.O. Phillips, et al. 2007 Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 1943 1950 10.1016/j.jacc.2007.02.037 1:CAS:528:DC%2BD2sXlt1amtLw%3D 17498579 (Pubitemid 46694287)
7. G.I. Galasko S.C. Barnes P. Collinson, et al. 2006 What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 27 193 200 10.1093/eurheartj/ehi559 16267076 (Pubitemid 43069036)
8. S. Gielen M. Sandri G.C. Schuler 2006 [Acute heart failure: rational diagnostics in clinical practice and the emergency department.] Herz 31 736 747 10.1007/s00059-006-2916-5 17149675 (Pubitemid 44940005)
9. J.L. Januzzi Jr C.A. Camargo S. Anwaruddin, et al. 2005 The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 948 954 10.1016/j.amjcard.2004.12.032 1:CAS:528:DC%2BD2MXjtlWjurs%3D 15820160 (Pubitemid 40487743)
10. P. Jourdain G. Jondeau F. Funck, et al. 2007 Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study J Am Coll Cardiol 49 1733 1739 10.1016/j.jacc.2006.10.081 1:CAS:528:DC%2BD2sXksFWqtbg%3D 17448376 (Pubitemid 46589928)
11. C. Kragelund B. Gronning L. Kober, et al. 2005 N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease N Engl J Med 352 666 675 10.1056/NEJMoa042330 1:CAS:528:DC%2BD2MXhtlGhtLs%3D 15716560 (Pubitemid 40239214)
12. R. Latini S. Masson I.S. Anand, et al. 2007 Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure Circulation 116 1242 1249 10.1161/CIRCULATIONAHA.106.655076 1:CAS:528:DC%2BD2sXpvFWksbY%3D 17698733 (Pubitemid 47517535)
13. B. Levine J. Kalman L. Mayer, et al. 1990 Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 236 241 1:STN:280:DyaK3czgvF2isA%3D%3D 2195340
14. A.S. Maisel P. Krishnaswamy R.M. Nowak, et al. 2002 Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 161 167 10.1056/NEJMoa020233 1:CAS:528:DC%2BD38Xlt12jsL8%3D 12124404 (Pubitemid 34764819)
15. J. Mant J. Doust A. Roalfe, et al. 2009 Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care Health Technol Assess 13 1 207 1:STN:280:DC%2BD1MvntlCltA%3D%3D 19586584
16. P.A. McCullough P. Duc T. Omland, et al. 2003 B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study Am J Kidney Dis 41 571 579 10.1053/ajkd.2003.50118 1:CAS:528:DC%2BD3sXisVOjurY%3D 12612980 (Pubitemid 36278374)
17. W.L. Miller K.A. Hartman M.F. Burritt, et al. 2007 Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 249 257 10.1161/CIRCULATIONAHA.107.694562 1:CAS:528:DC%2BD2sXnsVyjsr4%3D 17592074 (Pubitemid 47196560)
18. R. Mogelvang J.P. Goetze P. Schnohr, et al. 2007 Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide J Am Coll Cardiol 50 1694 1701 10.1016/j.jacc.2007.07.073 1:CAS:528:DC%2BD2sXhtF2qsr%2FE 17950153 (Pubitemid 47562682)
19. D.A. Morrow J.A. de Lemos M.A. Blazing, et al. 2005 Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease JAMA 294 2866 2871 10.1001/jama.294.22.2866 1:CAS:528:DC%2BD2MXhtlWrtLfE 16352794 (Pubitemid 41785867)
20. C. Mueller A. Scholer K. Laule-Kilian, et al. 2004 Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 647 654 10.1056/NEJMoa031681 1:CAS:528:DC%2BD2cXhtFCrtro%3D 14960741 (Pubitemid 38364623)
21. M.M. Redfield R.J. Rodeheffer S.J. Jacobsen, et al. 2002 Plasma brain natriuretic peptide concentration: impact of age and gender J Am Coll Cardiol 40 976 982 10.1016/S0735-1097(02)02059-4 1:CAS:528:DC%2BD38Xns1OmsLc%3D 12225726 (Pubitemid 34994995)
22. R.J. Rodeheffer 2004 Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? J Am Coll Cardiol 44 740 749 1:CAS:528: DC%2BD2cXmslegu78%3D 15312852
23. M. Shimpo D.A. Morrow E.O. Weinberg, et al. 2004 Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation 109 2186 2190 10.1161/01.CIR. 0000127958.21003.5A 1:CAS:528:DC%2BD2cXjs1eisrs%3D 15117853 (Pubitemid 38625395)
24. P.G. Steg L. Joubin J. McCord, et al. 2005 B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea Chest 128 21 29 10.1378/chest.128.1.21 1:CAS:528:DC%2BD2MXnvFyqsbY%3D 16002911 (Pubitemid 40994449)
25. W.H. Tang G.S. Francis D.A. Morrow, et al. 2007 National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure Circulation 116 e99 109 10.1161/CIRCULATIONAHA.107.185267 1:CAS:528:DC%2BD2sXotValtL8%3D 17630410 (Pubitemid 47450268)
26. R.R. van Kimmenade J.L. Januzzi Jr 2009 Whose heart will get broken? Troponin testing and future heart failure Eur Heart J 30 755 756 10.1093/eurheartj/ehp092 19264751
27. C.S. Wang J.M. FitzGerald M. Schulzer, et al. 2005 Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 294 1944 1956 10.1001/jama.294.15.1944 1:CAS:528:DC%2BD2MXhtFCitLnL 16234501 (Pubitemid 41464696)
28. S.P. Wright R.N. Doughty A. Pearl, et al. 2003 Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial J Am Coll Cardiol 42 1793 1800 10.1016/j.jacc.2003.05.011 1:CAS:528:DC%2BD3sXpvVGjsbw%3D 14642690 (Pubitemid 37433660)
29. A.H. Wu A. Smith S. Wieczorek, et al. 2003 Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure Am J Cardiol 92 628 631 10.1016/S0002-9149(03)00741-0 1:CAS:528:DC%2BD3sXms12isbw%3D 12943894 (Pubitemid 37013426)